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No white matter  abnormalities  in  pediatric,  unmedicated  bipolar  disorder.
No  white matter  abnormalities  in  young,  healthy  offspring.
Disease  ontogeny  and  brain  development  dynamics  may  explain  differences  in  ﬁndings.
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White  matter  (WM)  abnormalities  have  been  reported  in bipolar  disorder  (BD)  patients,  as well as  in  their
non-BD relatives,  both  children  and adults.  Although  it is considered  an  emerging  vulnerability  marker
for BD,  there  are  no studies  investigating  WM  alterations  in  pediatric  unmedicated  patients  and  young
healthy  offspring.  In this  study,  we  evaluated  the  presence  of WM  alterations  in 18  pediatric,  non  medi-
cated  BD  patients,  as well as  in  18  healthy  offspring  of  BD  type I parents  and 20 healthy  controls.  3T DT-MRI
data  were  acquired  and  scans  were  processed  with  tract-based  spatial  statistics  to provide  measures  ofipolar disorder
hildren
T-MRI
hite matter
ffspring
fractional  anisotropy  and  diffusivity.  We  found  no signiﬁcant  differences  in WM  microstructure  between
BD  patients,  healthy  offspring  and healthy  controls.  Previous  studies  that  reported  WM  alterations  inves-
tigated older  subjects,  either  on medication  (BD  patients)  or  with  psychiatric  diagnoses  other  than  BD
(unaffected  offspring).  Our  ﬁndings  highlight  the  importance  of  the  understanding  of disease  ontogeny
and  brain  development  dynamics  in the  search  for  early  vulnerability  markers  for psychiatric  disorders.
©  2014  Elsevier  Ireland  Ltd.  All  rights  reserved.. Introduction
Bipolar disorder (BD) affects up to 2.5% of the adult and ado-
escent populations [1,2], but its ethyology and pathophysiology
emain elusive. There is compelling evidence that the early-onset
orm of the disease (prior to age 18) displays signiﬁcant differ-
nces compared to the late-onset presentation [3]. Considering that
rain development is a dynamic, genetically predetermined and
nvironment-dependent process, cross-sectional imaging stud-
es of the same disease in different stages of neurodevelopment
∗ Corresponding author at: Bipolar Disorder Research Program, Rua Dr. Ovídio
ires de Campos, 785, São Paulo 05403-010, SP, Brazil. Tel.: +55 11 26617928;
ax: +55 11 2661 7928.
E-mail address: ana.arist@gmail.com (A.M.A. Teixeira).
ttp://dx.doi.org/10.1016/j.neulet.2014.06.061
304-3940/© 2014 Elsevier Ireland Ltd. All rights reserved.(e.g., childhood, late adolescence) may  yield signiﬁcantly different
results. It means that not only the clinical and methodological dif-
ferences among studies should be taken into account, but also the
ontogenetic aspects of the disorder itself.
It is also important to consider that BD is a progressive disease
[4], and that many structural alterations that have been associated
to it may  be chieﬂy a scarring effect of repeated mood episodes
[5] and/or continued medication exposure [6,7]. Hence, it is of
paramount importance to assess unmedicated patients early in
the course of the disease. Furthermore, healthy relatives, such
as healthy BD offspring (HO), can constitute an important model
by putatively displaying a number of disease-associated markers
without the complete disease phenotype.
White matter abnormalities detected by Diffusion Tensor
Magnetic Resonance Imaging (DT-MRI) have been consistently
reported both in BD patients [8,9] and in their non-BD relatives
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n adulthood [10–12]. Children and adolescents with BD also
ave been found to display decreased fractional anisotropy (FA), a
easure of ﬁbers coherence and organization, but ﬁndings differ
cross studies [13–15]. Results on young, unaffected BD relatives
re even more heterogeneous [16–18]. It is important to notice that
T-MRI studies with unaffected BD relatives frequently include
ubjects with current or past history of other psychiatric diagnoses
r subthreshold mood symptoms.
Our aim in this study was to evaluate the presence of white
atter alterations in healthy children at risk, as well as in pediatric,
on medicated BD patients, using DT-MRI.
. Method
This study was undertaken in accordance with the guidance of
he Ethics Committee of the University of Sao Paulo. Informed con-
ent was obtained from parent or legal guardian, and assent was
btained from all subjects.
.1. Participants
Healthy offspring of adult BD patients were included if they: (a)
ere between 6 and 17 years of age; (b) had at least one parent with
D type I diagnosis according to DSM-IV-R criteria; and (c) had no
ifetime history of DSM-IV axis I diagnosis. Pediatric BD patients
ere recruited from the outpatient clinic of the Bipolar Disorder
esearch Program and included if they: (a) were between 6 and
7 years of age; (b) fulﬁlled DSM-IV-R criteria for BD; and (c) were
ot taking psychotropic medication for at least four weeks prior to
he examination. Healthy controls (HC) within the same age range
ere recruited through advertisement and included if they had no
ersonal or family history of any DSM-IV axis I diagnosis. Exclusion
riteria for the entire sample were: (a) head trauma resulting in loss
f consciousness; (b) neurological or medical disorders; (c) IQ < 70;
nd (c) substance use disorders.
.2. Clinical assessment
Children and adolescents were interviewed using the Schedule
or Affective Disorders and Schizophrenia for School-Age Children-
resent and Lifetime Version (K-SADS-PL) [19]. All interviews were
ated by trained psychologists and child psychiatrists and reviewed
y board certiﬁed child psychiatrists (AK and SCC). Children and
dolescents were diagnosed as BD NOS if they presented clear
anic or hypomanic episodes with elation and/or grandiosity
ut lacked the duration needed to be classiﬁed as BD I or BD II
20]. Patients were rated using the Children Depression Rating
cale—Revised (CDRS-R) [21], the Young Mania Rating Scale (YMRS)
22] and the Clinical Global Impression Scale (CGI) [23]. Pubertal
tatus of all participants was assessed using the Petersen Pubertal
cale [24]. Parental diagnoses were obtained using the Structured
linical Interview for the DSM-IV (SCID-1) [25]. Intelligence scores
ere assessed using Wechsler Abbreviated Scale of Intelligence
26].
.3. Neuroimaging data acquisition
Gradient echo planar MR  images were acquired using a 3.0T
hilips Achieva MR  system (Philips Healthcare, USA) ﬁtted with
0 mT/m highspeed gradients. Foam padding and a forehead
trap were used to limit head motion, and a quadrature bird-
age head coil was used for radio frequency transmission and
eception. Data acquisition parameters for the DTI scan were
epetition time (TR) = 6106 ms,  echo time (TE) = 65 ms,  ﬁeld of
iew (FOV) = 224 × 224 mm,  slice thickness = 2 mm,  no gap, numbere Letters 579 (2014) 41–45
of slices = 70, acquisition matrix = 112 × 112, number of diffu-
sion gradient directions = 32, b = 0 and 1000 s/mm2, number of
averages = 3, and the total scan time = 24 min. The MRI proto-
col also included a tridimensional (3-D) T1-weighted imaging
using a fast spoiled gradient-echo sequence (TR = 7 ms,  TE = 3.2 ms,
FOV = 240 × 240 × 180, slice thickness = 1 mm,  no gap, number
of averages = 1, acquisition matrix = 240 × 240). All scans were
reviewed by a radiologist to ensure that no gross brain abnormali-
ties were evident.
2.4. Statistical analysis
2.4.1. Clinical data
Statistical analyses were performed with the SPSS software,
version 14 (SPSS, Inc., Chicago, IL). We  adopted a 2-tailed sig-
niﬁcance level of 0.05. We  tested the data distribution using the
Kolmogorov–Smirnov Z test. To compare demographic and clini-
cal characteristics among the three groups, we  used analyses of
variance (ANOVA) and chi-square tests.
2.4.2. DT-MRI data
Diffusion-weighted images were ﬁrst aligned to the B0 image by
Fourier interpolation [27]. Head motion and eddy current-induced
distortion correction were performed using the “eddy current”
script, and brain segmentation was  carried out by the software
“bet”, both implemented in the FSL toolbox [28]. Subsequently, the
software “dtiﬁt”, which is implemented in FSL, was  used to com-
pute the image tensor using the adjusted diffusion-weighed and B0
images and a simple least squares ﬁt. Group comparisons were car-
ried out using the tract-based spatial statistics (TBSS) approach on
the FSL software [29]. Voxelwise analyses of data were performed
using permutation-based inference as implemented in Randomise
[30] in FSL using threshold-free cluster enhancement (TFCE) [31].
Linear effects of diagnostic group on FA, MD,  RD and AD were tested
using general linear models with age as covariate. Five thousand
permutations were performed for each contrast. Statistical maps
were thresholded at P < 0.05, fully corrected for multiple compar-
isons (family-wise error). Region of interest (ROI) analyses were
performed using probabilistic WM ROIs included in FSL comprising
11 tracts, two of which were considered a priori regions: cor-
pus callosum and cingulum. The mean voxel intensity value was
obtained for each skeletonized ROI for the three groups, and group
means were compared with analyses of covariance (ANCOVA), with
age as covariate.
3. Results
Sociodemographic variables are displayed in Table 1. Groups
did not differ in age, gender, IQ, puberty degree or socioeconomic
status.
3.1. Clinical characteristics
The BD group was comprised by children and adolescents diag-
nosed with BD type I (n = 8), BD type II (n = 2) and BD NOS  (n = 8).
At scan time, BD patients were in mania (n = 6), mixed (n = 4) or
euthymia (n = 8). The mean age at BD onset (SD) was  9.5 (3.9) years
old. The mean Young Mania Rating Scale (SD) was  8.7 (6.1) and
the mean Children’s Depression Rating Scale score (SD) was 28.9
(12.6). The mean Clinical Global Impression Scale score (SD) was
4.1 (1.1). BD patients (n = 14) had comorbidities with attention
deﬁcit hyperactivity disorder (n = 9), oppositional deﬁant disor-
der (n = 5), generalized anxiety disorder (n = 3), conduct disorder
(n = 2), simple phobia (n = 2), post-traumatic stress disorder (n = 2),
panic disorder (n = 1), separation anxiety disorder (n = 1), obsessive-
compulsive disorder (n = 1) and Tourette (n = 1). Nine (50%) BD
A.M.A. Teixeira et al. / Neuroscience Letters 579 (2014) 41–45 43
Table  1
Sample sociodemographic characteristics by diagnostic group and statistics.
Variable BD (n = 18) HO (n = 18) HC (n = 20) F or 2 P
Age (years), mean (SD) 12.3 (2.8) 12.7 (3.1) 12.7 (2.6) 0.13* 0.88
Gender, % female 6 (33.3) 10 (50.0) 6 (33.3) 1.50** 0.47
Ethnicity 2.90** 0.82
White, n (%) 10 (55.5) 12 (66.6) 11 (55.0)
Black, n (%) 1 (5.5) 1 (5.5) 2 (10.0)
Mixed, n (%) 6 (33.3) 5 (27.8) 7 (35.0)
Asian, n (%) 1 (5.5) 0 0
IQ,  mean (SD) 94.4 (15.5) 92.1 (7.9) 97.1 (14.1) 0.65* 0.53
Socioeconomic class (scorea) 0.18** 0.92
A  (≥89), n (%) 2 (6.3) 0 1 (6.7)
B  (59–88), n (%) 7 (37.5) 6 (33.3) 9 (40.0)
C  (35–58), n (%) 8 (50.0) 8 (46.7) 9 (53.3)
D  (20–34), n (%) 1 (6.3) 0 0
Education (years), mean (SD) 6.8 (2.6) 7.5 (2.8) 8.1 (2.6) 0.92** 0.40
Pubertal development 2.8** 0.95
Prepubertal, n (%) 2 (11.1) 3 (16.6) 5 (25.0)
Early  pubertal, n (%) 3 (16.6) 4 (22.2) 3 (15.0)
Midpubertal, n (%) 6 (33.3) 3 (16.6) 4 (20.0)
Late  pubertal, n (%) 5 (27.8) 5 (27.8) 5 (25.0)
Postpubertal, n (%) 2 (11.1) 3 (16.6) 3 (15.0)
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a Brazilian Association of Market Research Institutes Demographic and Socioecon
atients had mood congruent psychotic symptoms. BD patients
ere either medication-naïve (n = 10) or were off medication for
t least 4 weeks (n = 8).
.2. Neuroimaging results
TBSS results showed no signiﬁcant differences in FA, MD,  RD
r AD indices between BD, HO, and HC, both in the whole-brain
airwise comparisons (Fig. 1) and ROI analyses. ROI indices for all
hite matter tracts analyzed are shown in Table 2.
. Discussion
In this young, unmedicated sample, we did not ﬁnd any sig-
iﬁcant white matter differences across diagnostic groups. The
ost replicated white matter ﬁnding in pediatric BD seems to
e decreased FA in anterior corpus callosum [14,32,33], followed
y decreased FA in the anterior cingulate and cingulate gyrus
15,16,33], and in the corona radiata [33,34]. In most previous
ig. 1. TBSS statistical maps showing no clusters of higher FA in controls compared
o BD (P < 0.05), both in the TCFE-corrected (left) and uncorrected (right) maps. A:
nterior; P: posterior.Class Scale [48].
studies, though, participants were on medication, and subjects’
mean age was usually 2–3 years older compared to the present
study. Only Lu et al. [35] evaluated unmedicated pediatric BD,
and found lower FA in the anterior limb of the internal capsule.
However, their data had low spatial resolution, and they did not
have any ﬁndings in larger white matter tracts, neither in children
nor in adults, suggesting results could be a partial volume artifact.
We used an ROI approach to investigate speciﬁc WM tracts,
including the largest and most frequently implicated in pediatric
BD (corpus callosum and cingulum bundles), but failed to ﬁnd any
differences across groups.
Our choice for scanning preferentially drug-naïve subjects led
to a particularly young sample of BD patients. Despite the ongoing
controversy of BD diagnosis in prepubertal children, we  consider
that our sample may  provide important information regarding the
underlying neurobiology of BD. First, half of our sample, though
young, was  classiﬁed as BD type I, fulﬁlling diagnostic criteria for
classic mania presentation. Children diagnosed as BD not other-
wise speciﬁed (NOS) had to present clear manic or hypomanic
symptoms, including elated mood. None of our subjects presented
with irritable mood only. All BD patients in this sample have been
followed up in our services, and there have been no changes in
diagnoses.
We evaluated children across a wide age range, but the majority
(63%) was aged between 8 and 12. Since longitudinal MRI  studies
in BD suggest loss of gray matter with disease progression, partic-
ularly in the prefrontal, anterior cingulate and subgenual cortices
[36], and considering these are late-maturing brain regions [37,38],
part of our subjects are expected to be undergoing dramatic struc-
tural changes—while others may  not even have started to mature
at the studied age range. Considering BD causes alterations in brain
structure that are relatively mild [5] and that even patients with
late-onset BD usually have had symptoms since childhood [39], we
could hypothesize these young patients are less likely to exhibit
scarring effects of prolonged disease and, therefore, the single most
important factor accounting for the between-subjects variability
could be pubertal development.
As subjects become older, age differences may  become pro-
gressively less important in DT-MRI studies, but at this age range,
intense pruning and myelination processes are taking place [40]
and may  be more evident than smaller-scale disease-provoked
alterations. Furthermore, it has been proposed that the typical
44 A.M.A. Teixeira et al. / Neuroscience Letters 579 (2014) 41–45
Table  2
Mean ROI FA indices for the three diagnostic groups.
Tract Hemisphere BD mean (SD) HO mean (SD) HC mean (SD) F P
CC – 0.318 (0.056) 0.344 (0.017) 0.348 (0.100) 1.163 0.322
Cingulum Left  0.275 (0.049) 0.310 (0.034) 0.298 (0.095) 1.517 0.231
Right 0.209 (0.049) 0.255 (0.035) 0.244 (0.101) 2.439 0.099
ATR Left  0.296 (0.054) 0.313 (0.015) 0.328 (0.095) 1.150 0.326
Right 0.323 (0.052) 0.323 (0.016) 0.341 (0.099) 0.481 0.622
CST Left  0.368 (0.056) 0.394 (0.021) 0.400 (0.097) 1.276 0.289
Right 0.403 (0.042) 0.412 (0.021) 0.430 (0.088) 0.960 0.391
SLF Left  0.295 (0.047) 0.323 (0.024) 0.331 (0.088) 0.763 0.472
Right 0.296 (0.046) 0.312 (0.028) 0.317 (0.098) 0.554 0.578
UF Left  0.265 (0.048) 0.277 (0.017) 0.297 (0.090) 1.325 0.276
323 (0
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bbreviations: CC, corpus callosum; ATR, anterior thalamic radiation; CST, corticos
D and schizophrenia mean age of onset – late adolescence – is
ssociated with a deregulation of later maturational processes in
he brain, such as abnormal myelination or altered expression of
eurotransmitters and their receptors [41,42]. Consequently, brain
lterations would become visible as the patients become older and
heir brain development trajectories begin to visibly deviate from
he typical course.
It is also important to consider this was an unmedicated BD
ample, half of which was drug-naïve. Youth with BD are pre-
cribed antipsychotic medication more often than adults [43] and,
hough antipsychotics may  acutely increase frontal lobe intracor-
ical myelin volume, chronic use may  exert the opposite effect
44,45]. Moreover, a recent longitudinal study with drug-naïve
atients with schizophrenia showed differences in FA indices only
fter medication: after 6 weeks of antipsychotic treatment patients
howed decreased FA when compared to healthy controls and to
aseline [46].
The most relevant limitation to our study is the relatively mod-
st size of the sample. However, it should be noted that our sample
s of comparable [17,35] or larger [32,47] size than those included
n most DT-MRI studies that have reported white matter abnormal-
ties in BD groups of older age and/or with a history of continuous
edication exposure.
In conclusion, there is a growing body of evidence associating
D to gray and white matter abnormalities. Nevertheless, hetero-
eneity among studies is high and should be properly addressed.
ur study offers another evidence for the hypothesis of neuropro-
ression in BD, suggesting that unmedicated pediatric patients do
ot carry observable white matter alterations, despite displaying
he complete disease phenotype. Similarly, white matter abnor-
alities are also absent in healthy, young offspring of BD parents.
uture longitudinal studies are warranted to evaluate the progres-
ion of structural alterations in BD pediatric patients and to further
nvestigate possible vulnerability markers in offspring at high-risk
or BD.
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